T1	Lab_value_phrase 401 500	Biochemical testing revealed elevated level of acid phosphatase (47.8 IU/L [normal range 5–7 IU/L])
T2	Lab_value 466 475	47.8 IU/L
T3	Diagnostic_procedure 453 464	phosphatase
T4	Lab_value_phrase 505 591	chitotriosidase activity (508 nmol/mg protein [normal range 5.9–41.0 nmol/mg protein])
T5	Lab_value 531 542	508 nmol/mg
T6	Diagnostic_procedure 505 520	chitotriosidase
T7	Lab_value_phrase 593 698	as well as reduced beta-glucosidase activity (2 nmol/mg/protein [normal range 4.5–18.0 nmol/mg/protein]).
T8	Lab_value 639 656	2 nmol/mg/protein
T9	Diagnostic_procedure 612 628	beta-glucosidase
T10	Lab_value_phrase 834 917	The patient began ERT at a dosage of 60 U/kg every 2 weeks at the age of 18 months.
T11	Lab_value 871 878	60 U/kg
T12	Diagnostic_procedure 861 867	dosage
T13	Lab_value_phrase 1453 1506	target dose (100 mg three times daily) after 1 month.
T14	Lab_value 1466 1472	100 mg
T15	Diagnostic_procedure 1460 1464	dose
